Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Tyler Shugg, Emma M. Tillman, Amy M. Breman, Jennelle C. Hodge, Christine A. McDonald, Reynold C. Ly, Elizabeth J. Rowe, Wilberforce Osei, Tayler B. Smith, Peter H. Schwartz, John T. Callaghan, Victoria M. Pratt, Sheryl Lynch, Michael T. Eadon, Todd C. Skaar
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Clinical Pharmacology & Therapeutics
Online Access:https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3402
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View

Internet

https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3402

Similar Items

  • Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs
    by: Hyunwoo Koo, et al.
    Published: (2025)
  • Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y12 Inhibitor Prescribing
    by: Ashley N. Springer, et al.
    Published: (2025)
  • Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
    by: Tyler Shugg, et al.
    Published: (2025)
  • A software security review on Uganda's Mobile Money Services: Dr. Jim Spire's tweets sentiment analysis
    by: Wilberforce, Nsengiyumva
    Published: (2025)
  • Colonialism, Capitalism and Racism
    by: Breman, Jan
    Published: (2025)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs